Side effects and acceptability of Implanon®: A pilot study conducted in eastern Turkey

European Journal of Contraception and Reproductive Health Care

Volumn 12, Issue 3, 2007, Pages 248-252

  Yildizbas, Beyhan ^a   Sahin, H Guler ^a   Kolusari, Ali ^a   Zeteroglu, Sahin ^a   Kamaci, Mansur ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Acceptability; Adverse effects; Bleeding; Implanon

Indexed keywords

CHOLESTEROL; ESTRADIOL; ETONOGESTREL; PROTEIN C;

ACNE; ADULT; AMENORRHEA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DIZZINESS; DRUG INDUCED HEADACHE; DYSMENORRHEA; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; IMPLANT; MASTALGIA; MENSTRUAL CYCLE; MENSTRUATION; MOOD CHANGE; NAUSEA; PREGNANCY; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL ANALYSIS; STUDENT T TEST; TURKEY (REPUBLIC); WEIGHT GAIN;

ACNE VULGARIS; ADOLESCENT; ADULT; BREAST DISEASES; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DEVICE REMOVAL; DIZZINESS; DRUG IMPLANTS; ENDOMETRIUM; FEMALE; HUMANS; MEDICAL RECORDS; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; MOOD DISORDERS; NAUSEA; PAIN; PATIENT SATISFACTION; PILOT PROJECTS; TURKEY; WORLD HEALTH ORGANIZATION;

EID: 34548304498     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180701442228     Document Type: Article

References (13)

1. Mascarenhas L. Insertion and removal of Implanon: Practical considerations. Eur J Contracept Reprod Health Care 2000;5(Suppl 2):29-34.
2. Zeteroglu S, Sahin G, Sahin HA, Bolluk G. Knowledge and attitudes towards emergency contraception of health care providers in a region with a high birth rate. Eur J Contracept Reprod Health Care 2004;9: 102-6.
3. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 1997;55:57-65.
4. Booranabunyat S, Taneepanichskul S. Implanon use in Thai women above the age of 35 years. Contraception 2004;69:489-91.
5. Dorflinger LJ. Metabolic effects of implantable steroid contraceptives for women. Contraception 2002;65:47-62.
6. Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon. Contraception 1998;58:91S-7S.
7. Egberg N, vanBeek A, Gunnervik C, et al. Effects on the haemostatic system and liver function in relation to Implanon and Norplant. Contraception 1998;58:93-8.
8. Bitzer J, Tschudin S, Alder J. Acceptability and side-effects of Implanon in Switzerland: A retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care 2004;9:278-84.
9. Meckstroth KR, Darney PD. Implant contraception. Semin Reprod Med 2001;19:339-54.
10. Otero Flores JB, Balderas ML, Bonilla MC, Vazquez-Estrada L. Clinical experience and acceptability of the etonogestrel sub dermal contraceptive implant. Int J Gynecol Obstet 2005;90:228-33.
11. Kiriwat O, Patanayindee A, Koetsawang S, et al. A 4 year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand. Eur J Contracept Reprod Health Care 1998;3:85-91.
12. Funk S, Miller MM, Mishell DR Jr, et al. for the Implanon US study group. Safety and efficacy of Implanon, a single rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319-26.
13. Urbancsek J. An integrated analysis of nonmenstrual adverse events with Implanon. Contraception 1998;58:109S-15S.